About T-cell surface antigen CD2
T-cell surface antigen CD2 (CD2) is a protein
from Homo sapiens identified by UniProt accession
P06729, 351 residues long.
MolForge cross-references it against 0 known binders and
400 disease associations.
Target properties
| Protein name | T-cell surface antigen CD2 |
| UniProt accession | P06729 |
| Gene | CD2 |
| Organism | Homo sapiens |
| Length | 351 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (400)
Diseases linked to this target (Open Targets).
- psoriasis · score 0.64
- immune system disease · score 0.37
- pityriasis rubra pilaris · score 0.37
- atopic eczema · score 0.37
- eosinophil count · score 0.33
- rheumatoid arthritis · score 0.32
- thyroid disease · score 0.30
- Thyroid preparation use measurement · score 0.30
- graft versus host disease · score 0.27
- eosinophil percentage of leukocytes · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P06729-F1 | alphafold | PREDICTED | 77.72 | — |
Amino-acid sequence (351 residues)
MSFPCKFVAS FLLIFNVSSK GAVSKEITNA LETWGALGQD INLDIPSFQM SDDIDDIKWE KTSDKKKIAQ FRKEKETFKE KDTYKLFKNG TLKIKHLKTD DQDIYKVSIY DTKGKNVLEK IFDLKIQERV SKPKISWTCI NTTLTCEVMN GTDPELNLYQ DGKHLKLSQR VITHKWTTSL SAKFKCTAGN KVSKESSVEP VSCPEKGLDI YLIIGICGGG SLLMVFVALL VFYITKRKKQ RSRRNDEELE TRAHRVATEE RGRKPHQIPA STPQNPATSQ HPPPPPGHRS QAPSHRPPPP GHRVQHQPQK RPPAPSGTQV HQQKGPPLPR PRVQPKPPHG AAENSLSPSS N
Explore T-cell surface antigen CD2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets